Everybody wants to know whether the fat goes away. Here’s the question I’d ask first. How does the area look and feel after the swelling settles?
What side effects did researchers actually report?
In one randomized Phase 2b study, injection-site reactions were common. Researchers described most events as mild or moderate, and local reactions generally resolved on their own. Four of 52 participants in the CBL-514 safety group stopped because of injection-site hives or pain. The table shows reported reactions during the study. Lorenc et al., safety results
| Injection-site reaction | CBL-514 (52) | Placebo (55) |
|---|---|---|
| Pain | 38 (73.1%) | 20 (36.4%) |
| Swelling | 36 (69.2%) | 17 (30.9%) |
| Bruising | 37 (71.2%) | 28 (50.9%) |
| Induration (firm or hardened tissue) | 22 (42.3%) | 6 (10.9%) |
Phase 2b · Reported injection-site reaction
Induration (firm or hardened tissue)
Phase 2b trial registration (NCT05736107)
Could CBL-514 leave lasting lumps, dents or asymmetry?
Induration is a documented finding. How often CBL-514 leaves lasting bumps, dents or visible asymmetry remains an open question. The published induration figure counts reported firmness during the trial and cannot be used as a rate of permanent contour problems. Uneven fat reduction, differences in local tissue response and scarring are reasonable questions for follow-up. To answer them, researchers would need to track how long changes last, where they occur, and whether independent reviewers can see them after swelling resolves.
What does the CoolSculpting comparison tell us?
Paradoxical adipose hyperplasia, or PAH, is a documented complication of fat freezing in which fat tissue in the treated area enlarges. The FDA describes PAH as unique to fat freezing. The comparison raises a fair question about whether short trials catch delayed cosmetic outcomes. It gives us no CBL-514 PAH rate. FDA body-contouring overview · Published cryolipolysis case series
What do Reddit reviews add?
One poster describing participation in a blinded study reported early discomfort and said they did not know whether they received CBL-514 or placebo. That is a useful reminder that feeling an injection tells you little about which group you were in. A forum report can surface questions about pain, firmness and appearance. It cannot tell us how common a reaction is or establish what was in an online vial. Community discussion
Is CBL-514 a scam?
CBL-514 is a real investigational drug with published human research. Claims that an online vial is equivalent to the clinical formulation or that it can safely reproduce study results require separate evidence. The FDA has reported infections, scarring and deformities after other unapproved fat-dissolving injections. Those reports provide context about the risks of online injectables and do not supply adverse-event rates for CBL-514. FDA warning on unapproved fat-dissolving injections · Xcel’s CBL-514 clinical research guide